October 31, 2017
Novartis waits second indication Kymriah to reach more patients
Novartis said on Tuesday that it has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
October 30, 2017
Mereo BioPharma agrees with AstraZeneca for exclusive license and option to acquire AZD9668
Mereo BioPharma has made a deal with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an oral inhibitor…
October 30, 2017
Hemogenyx selects LakePharma as its service provider for making CDX bi-specific antibodies
Hemogenyx Pharmaceuticals has picked LakePharma as its service provider for the development and manufacturing of Hemogenyx’s lead product, CDX bi-specific…
October 30, 2017
Novartis expands its oncology arm with AAA
Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…
October 27, 2017
Sandoz is seeking approval for use of its biosimilar to Amgen’s Neulasta, EMA to take a look at it
Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…
October 26, 2017
Russian biotechnology company BIOCAD enters the European market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there…
October 26, 2017
New biopharma event alongside CPhI Worldwide 2018 in Madrid
UBM’s pharma portfolio will launch a new biopharma event, BioLive, next year in Madrid – specifically for bioprocessing and manufacturing. The new event has been…
October 25, 2017
BD kicks off $60 million expansion of Nebraska manufacturing facility
BD has broken ground on a $60 million upgrade of its Columbus-East facility on Wednesday.
October 25, 2017
UniQure cashes in $91,250,000 from the offering?
Dutch gene therapy company uniQure N.V. on wednesday announced the pricing of its underwritten public offering of 5,000,000 of its ordinary…
October 25, 2017
Ablynx prices $200M public offering, trades on NASDAQ
Belgian Ablynx on Wednesday announced the pricing of its initial U.S. public offering totaling $200 million, from 11,430,000 American Depositary…